Inari Medical, Inc. (NARI) Misses Q3 EPS by 19c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to Inari Medical, Inc. (NARI) Misses Q3 EPS by 19c, provides guidance
October 29, 2024 5:57 AM EDT
Truist Securities analyst Richard Newitter raised the price target on Inari Medical Inc. (NASDAQ: NARI) to $50.00 (from $46.00) while maintaining a Hold rating.
The analyst comments "NARI's 3Q profit beat shld help the stock recover a bit (up +9% AMC) some of its recent pullback... More
October 29, 2024 5:47 AM EDT
BTIG analyst Marie Thibault reiterated a Buy rating and $86.00 price target on Inari Medical Inc. (NASDAQ: NARI).
The analyst comments "Inari Medical reported Q3 revenue of $153.4M (+21.4% y/y and +5% sequentially), above consensus of $150.7M. NARI had previously set a Q3 sales outlook that implied ~$150M this ~$3M beat vs our expectations was driven by U.S. VTE and International sales growth. The full-year revenue outlook was... More
